New York Man Claims Risperdal Breast Growth Was Like “Living in Hell”
A New York man who claims that Risperdal turned his life into a nightmare has joined the growing ranks of plaintiffs seeking compensation from Johnson & Johnson.
“It was like living in hell,” 22-year-old Shaquil Byrd recently told the Albany Times-Union. “It made me feel like an outcast … I didn’t feel like I was a male or a female. I felt like I was kind of in between.”
According to a Risperdal lawsuit now pending in U.S. District Court in Albany, Byrd was prescribed the medication in 2002 while undergoing outpatient psychiatric treatment. Before he was 10-years-old, Byrd developed female-like breasts and had begun lactating. It wasn’t until 2014 that Byrd would undergo surgery to remove his excess breast tissue. In the interim, he endured taunts and bullying from peers who could not comprehend his abnormality.
“I mostly got bullied because of it. People asking if I have titties, asking if I need to wear my sister’s bra,” he told the Time-Union. “They constantly asked me if I had milk. They did a thing called a ‘scoop slam dunk’ and that was when they basically cuffed my chest and slapped it down. They actually grabbed my chest.”
To this day, Byrd will not remove his shirt in public. He is hoping that his Risperdal lawsuit will send a message to Johnson & Johnson about the folly of putting profits over patient safety.
According to RXInjuryHelp.com, Byrd is just one of thousands of plaintiffs who are currently pursuing Risperdal lawsuits over the its alleged association with gynecomastia. These individuals assert that Johnson & Johnson concealed the drug’s risks and failed to warn patients and doctors about the potential for male breast growth. They further claim that the company engaged in deceptive and misleading practices to drive sales of Risperdal, which once ranked among Johnson & Johnson’s best-selling medications.
One of the largest litigations involving Risperdal is currently underway in the Philadelphia Court of Common Pleas, where more than 1,700 cases have been centralized in a mass tort program. Last year, the court convened four gynecomastia trials, three of which concluded with monetary awards for plaintiffs.
There is still time for victim of gynecomastia to file their own Risperdal lawsuit. To learn more, please contact Bernstein Liebhard LLP at 877-779-1414.